Important lessons about human susceptibility to coronary atherosclerosis can be learned from the relative resilience of chimpanzees to coronary artery disease (CAD), despite their higher baseline plasma levels of LDL cholesterol and lipoprotein(a) than in humans. Evolutionary pressure and hyper-reactive T cells might have a role in the unique susceptibility of humans to CAD.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Vernon, S. T. et al. Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors. Eur. J. Prev. Cardiol. 24, 1824–1830 (2017).
Figtree, G. A. et al. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. Lancet 397, 1085–1094 (2021).
Varki, A. & Altheide, T. K. Comparing the human and chimpanzee genomes: searching for needles in a haystack. Genome Res. 15, 1746–1758 (2005).
Varki, N. et al. Heart disease is common in humans and chimpanzees, but is caused by different pathological processes. Evol. Appl. 2, 101–112 (2009).
Manning, G. W. Coronary disease in the ape. Am. Heart J. 23, 719–724 (1942).
Blaton, V. & Peeters, H. The nonhuman primates as models for studying human atherosclerosis: studies on the chimpanzee, the baboon and the rhesus macacus. Adv. Exp. Med. Biol. 67, 33–64 (1976).
Erdmann, J., Kessler, T., Munoz Venegas, L. & Schunkert, H. A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Cardiovasc. Res. 114, 1241–1257 (2018).
Soto, P. C., Stein, L. L., Hurtado-Ziola, N., Hedrick, S. M. & Varki, A. Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J. Immunol. 184, 4185–4195 (2010).
Nguyen, D. H., Hurtado-Ziola, N., Gagneux, P. & Varki, A. Loss of Siglec expression on T lymphocytes during human evolution. Proc. Natl Acad. Sci. USA 103, 7765–7770 (2006).
Okerblom, J. J. et al. Loss of CMAH during human evolution primed the monocyte–macrophage lineage toward a more inflammatory and phagocytic state. J. Immunol. 198, 2366–2373 (2017).
G.A.F. is grateful for grant support from the National Health and Medical Research Council (Australia), Heart Research Australia and the NSW Office of Health and Medical Research. J.C.K. acknowledges research support from the US National Institutes of Health (R01HL148167), a New South Wales government health grant (RG194194), the Bourne Foundation and Agilent. H.M.M. is supported by the International Society for the Advancement of Cytometry Marylou Ingram Scholars programme.
G.A.F. reports personal fees from AstraZeneca, CSL and Janssen; grants from Abbott Diagnostic; and a patent (Biomarkers and Oxidative Stress; US9638699B2) issued to the Northern Sydney Local Health District. J.C.K. is the recipient of an Agilent Thought Leader Award, which includes funding for research that is unrelated to the current manuscript.
Peer review information
Nature Reviews Cardiology thanks Renu Virmani and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
About this article
Cite this article
Figtree, G.A., Kovacic, J.C. & McGuire, H.M. Human susceptibility to coronary artery disease: lessons from chimpanzee resilience. Nat Rev Cardiol 19, 497–498 (2022). https://doi.org/10.1038/s41569-022-00738-1